Joseph Kim | Chief Scientific Officer
PROOFPILOT

Joseph Kim, Chief Scientific Officer, PROOFPILOT

As Chief Strategy Officer, Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot. Most recently serving in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office, he brings a wide array of pharmaceutical research industry knowledge, integrating his experience working for a wide variety of organizations, including multiple Sponsors such as Merck and Takeda (Shire), as well as CROs, and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.

Appearances:



Festival of Biologics Day 2 @ 12:40

Automating Deployment, Management and Compliance of Patient Devices in Clinical Research

The deployment of connected devices and wearables in clinical research opens up great promise in collecting data in a new way that can help to round out the picture of a set of clinical endpoints.  However, the logistics of doing so at scale in a way that helps participants remain compliant, with data flowing as intended, can be quite difficult if you rely on manual processes of site personnel, who are already burdened with a great deal of clinical responsibility. Learn how digital protocol automation can not only reduce site and patient burden, but greatly increase participant compliance during study conduct. 

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers